产品编号：P139937
产品规格：5mg
产品价格：面议
| 标准品编号: | P139937 |
| 名称: | Palbociclib-d4 Hydrochloride |
| 别名: | 6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one-d4 Hydrochloride; 6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazin-1-yl)pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one-d4 Hydrochloride; Ibrance-d4 Hydrochloride; PD 0332991-d4 Hydrochloride; PD 332991-d4 Hydrochloride; PD 991-d4 Hydrochloride |
| 参考CAS号: | unlabelled free base: 571190-30-2 |
| 分子式: | C₂₅H₂₇D₄N₇O₂ • HCl |
| 外观: | Yellow Solid |
| 分子量: | 465.583646 |
| 溶解度: | DMF, Methanol |
| 类别: | Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | Palbociclib-d4 Hydrochloride is an intermediate in synthesizing Palbociclib-d4 (P139901), an isotope labelled compound of Palbociclib (P139900). Palbociclib (P139900) is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. |
| 参考文献 | |
